Head and Neck Cancer Patient Blood Study
Protocol: STUDY00004413
Full Title
Investigation of lood Draw Assays to Quantitate Effects of Therapeutic Interventions in Patients with HPV-Induced Head amp Neck Cancer
Description
This study enrolls people who have head and neck cancer or tumor. The purpose of this study is to learn about whether levels of HPV (Human Papillomavirus) and a protein (P16) are related to the way people respond to treatment for head and neck cancer.

We expect you will be in this research study for about 3 months. You will be asked to give a total of 3 blood samples at regular, routine visit blood draws during your cancer treatment. These samples will be taken prior to chemotherapy, after chemotherapy, and post-surgery. Study takes place at ECMC in Buffalo, NY.
Compensation: No
Eligibility
-Patients at least 18 years of age.
-Patients who have been diagnosed with head and neck squamous cell carcinoma.
-Patients who have a pre-treatment biopsy of a pathologically confirmed p16/HPV positive tumor.
Age Group: Adults
Principal Investigator: Christopher Hughes
Contact(s)
Daniel Leon
dleon2@buffalo.edu
+1 716-859-4879
Want to Learn More?

Let us know how the study team can reach you. If you do not hear back within 2 business days, reach out to the study team directly at the contact information above or email ctsiresearch@buffalo.edu and someone will assist you.

Your information will be shared only with the research study team for recruitment purposes and designated CTSI personnel for project quality assurance and will remain confidential. Your information will be stored indefinitely. Should you no longer want this information to be provided in the aforementioned ways, please contact ctsiresearch@buffalo.edu.